Metabolic screening in primary care for patients with schizophrenia or schizoaffective disorder and taking antipsychotic medication
| Autor: | Abhijit Bhat, Sophie Scarlet, Sally Carter, Lynne Chepulis, Rawiri Keenan, Shivam Deo, Kee Ping Lim, Chunhuan Lao, Muhammad Asim, Joanna Ly, Ruzaimah Mohammed, Ross Lawrenson |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2020 |
| Předmět: |
Male
medicine.medical_specialty medicine.medical_treatment Population Blood Pressure Schizoaffective disorder Audit Disease Electrocardiography 03 medical and health sciences Life Expectancy 0302 clinical medicine Residence Characteristics Risk Factors medicine Humans Mass Screening Body Weights and Measures 030212 general & internal medicine education Antipsychotic Glycated Hemoglobin education.field_of_study Primary Health Care business.industry Age Factors General Medicine Guideline medicine.disease Blood Cell Count Prolactin 030227 psychiatry Psychotic Disorders Cardiovascular Diseases Heart Disease Risk Factors Schizophrenia Emergency medicine Cohort Female Public aspects of medicine RA1-1270 business Antipsychotic Agents New Zealand |
| Zdroj: | Journal of Primary Health Care, Vol 12, Iss 1, Pp 29-34 (2020) |
| ISSN: | 1172-6156 |
| Popis: | ABSTRACT INTRODUCTIONLife expectancy in patients with schizophrenia is 15–20 years less than the general population. A dominant cause of morbidity and mortality in these patients is cardiovascular disease. Adverse consequences of modifiable cardiovascular risk factors can be reduced by regular monitoring of metabolic outcomes and intervention if required. AIMTo evaluate the metabolic screening in primary care for patients with schizoaffective disorders managed in primary care. To show the usefulness of combining simple practice audits in evaluating such areas of clinical practice. METHODSAn audit was undertaken in eight general practices in the Waikato and Bay of Plenty regions of New Zealand. Specifically, the monitoring of patients with schizophrenia or schizoaffective disorder whose antipsychotic medication was prescribed by primary care doctors was audited. Patient monitoring was compared to the guideline recommendation of the Royal Australian and New Zealand College of Psychiatrists (RANZCP) and the Best Practice Advisory Centre (BPAC). RESULTSIn total, 117 patients were included in the audit and none were fully monitored, as recommended by the RANZCP guidelines. Although two-thirds of patients had been evaluated for glycosylated haemoglobin (HbA1c), lipids, blood pressure, complete blood count and weight |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|